ADVERTISEMENTs
First ever US-India cancer dialogue held in New Delhi
The dialogue focused on cancer and the strengthening of US-India biomedical research cooperation, with the goal of jointly developing solutions to improve global health and well-being.
US Ambassador to India, Eric Garcetti. / U.S. Embassy in India
The first-ever US-India Cancer Dialogue was hosted in New Delhi on Aug. 5-6. The aim of the meeting was to strengthen biomedical research cooperation between the two nations.
The event, held at the National Institute of Immunology, saw participation from senior officials, experts, and researchers from both countries.
US Ambassador to India, Eric Garcetti, highlighted the significance of this collaboration, stating, "This exchange embodies the strength of the bond between our two great nations, built on a foundation of shared values, mutual respect, and a common vision for a healthier future; it's a tangible way to show how the United States and India are moving our partnership forward for health."
The dialogue focused on cancer and the strengthening of US-India biomedical research cooperation, with the goal of jointly developing solutions to improve global health and well-being. Nobel Laureate Dr. Jim Allison delivered a public lecture titled "Beyond Checkpoint Inhibition."
Participants included a US delegation, senior officials from the Indian government, leaders from the American and Indian private sectors, NGOs, patient advocacy groups, faculty members from Indian institutions, and young researchers. Senior officials from various US agencies, including the White House Office of Science and Technology Policy, the National Institutes of Health, the Food and Drug Administration, and the Department of Energy, were also present.
Cancer experts and scientists from Harvard University, the Mayo Clinic, the American Cancer Society, the Indian Council of Medical Research, the All India Institute of Medical Sciences, and Tata Memorial Hospital in Mumbai took part in the discussions.
Rajesh Gokhale, Secretary of the Department of Biotechnology, Ministry of Science and Technology, commented, "The Department of Biotechnology is committed to accelerating the discovery of innovative solutions towards cancer treatment through multidisciplinary approaches. The India-US Cancer Moonshot Dialogue, which included two days of scientific discussions, is a testament to our commitment to revolutionize cancer cure, leveraging biotechnology advancements for a cancer-free tomorrow."
Rajiv Bahl, Secretary to the Government of India, Department of Health Research, and Director General of the Indian Council of Medical Research, added, "The two-day scientific deliberation was very fruitful and will foster collaboration between people, organizations, and between public and private entities to identify potential areas of mutual interest between the two countries in cancer research and management."
The US-India Cancer Moonshot Dialogue, which was announced by President Joe Biden and Prime Minister Narendra Modi in June 2023, aims to advance cancer prevention, early detection, and treatment. This initiative will accelerate cooperation around AI-enabled innovation for cancer care, novel therapeutics, cost-effective equitable cancer therapy, cancer genomics, precision medicine, and clinical trials.
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
.png)
.png)
 (1).jpg)
.jpeg)
.png)
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login